January Newsletter
Highlights from our top news and latest initiatives.

 
Thank you for supporting the field of ID!

Thanks to the support of our donors and the generosity of Ferring Pharmaceuticals, we surpassed our goal and raised $60,000 for our 2022 action plan! The IDSA Foundation is deeply grateful to all those who share in our commitment to support infectious diseases specialists as they strengthen communities and save lives. Gifts made during the year-end campaign support the #FutureOfID by encouraging medical students, residents and fellows to select ID as their subspecialty and to support them in their career journeys. We look forward to continuing this work for years to come!  

Learn more about how we’re growing the FOUNDation of public health.  

Innovation & Opportunities in ID
Meet the Awardees: 2021 Microbial Pathogenesis
in Alzheimer’s Disease Grant

We are thrilled to announce the recipients of the 2021 Microbial Pathogenesis in Alzheimer’s Disease Grant! This year the Foundation awarded more than $1.7 million in grant funding to advance novel research into possible links between infectious diseases and the causation of Alzheimer’s disease.   

The 2021 grant recipients are: 

  • Ilia Baskakov, PhD, University of Maryland, Baltimore ($250,000) 

  • Elizabeth Bradshaw, PhD, Columbia University Medical Center ($250,000) 

  • Colette Cywes-Bentley, PhD, Brigham and Women’s Hospital ($250,000) 

  • Pinghui Feng, PhD, MS, University of Southern California ($250,000) 

  • Kristen Funk, PhD, University of North Carolina at Charlotte ($250,000) 

  • Mark Hicar, MD, PhD, University at Buffalo ($100,000) 

  • Xueyi Li, PhD, Massachusetts General Hospital ($100,000) 

  • Jason Tchieu, PhD, Cincinnati Children's Hospital Medical Center ($100,000) 

  • Richard Thompson, PhD, University of Cincinnati College of Medicine ($100,000) 

  • Ravinder Nagpal, PhD, Florida State University ($30,000) 

  • Kevin Zwezdaryk, PhD, Tulane University ($30,000) 

To learn more about the Microbial Pathogenesis in Alzheimer’s Disease Grant program, or for more information on projects from past awardees, visit IDSAFoundation.org/alz-research-grant.  
Read the press release
Apply for the 2022 G.E.R.M. Program 

There are less than three weeks left to apply for the 2022 Grants for Emerging Researchers/Clinicians Mentorship (G.E.R.M.) Program. HIVMA and the IDSA Foundation developed this program to provide grants to medical students interested in a career in ID or HIV medicine. Awardees will receive a $4,000 stipend to complete their project and will be paired with an IDSA or HIVMA member who will serve as a mentor. Medical students from populations underrepresented in medicine are encouraged to apply.  

The application deadline is Monday, Feb. 7. Learn more about why you should submit your application

Apply now
Explore the Dr. John G. Bartlett Education Series

Dive into the interesting and complex world of infectious diseases with the Dr. John G. Bartlett Education Series. Dedicated to the thought leadership and groundbreaking work of John G. Bartlett, MD, FIDSA, this series features lectures by esteemed ID professionals and patient advocates in the areas of C. diff, HIV and more.

Catch up on our most recent lectures: 

Our 2022 Industry Partners

The IDSA Foundation’s Industry Partners ensure our work continues for years to come. In 2021, our partners provided a critical $1,143,300 in financial support to advance the future of ID medicine. We’d like to extend a warm “thank you” to our continued and new 2022 supporters who share in our commitment to support the next generation of ID leaders. Their generosity makes it possible to provide the resources and funding needed to diversify and grow the ID workforce. We look forward to our partnerships and collaborations in 2022.  

Learn more about how to become an IDSA Foundation Industry Partner today! 

Twitter
Facebook
LinkedIn
Instagram
YouTube
Website
Copyright © 2021 IDSA Foundation, All rights reserved.

Our mailing address is:
4040 Wilson Boulevard
Suite 300
Arlington, VA 22203